Go SI - Search Results

1

The clinical impact of the sum of the maximum standardized uptake value on the pretreatment with F-FDG-PET/CT in small-cell lung cancer.

Go SI, Song HN, Kang JH, Kang MH, Kim MJ, Jung J, Chung SI, Choi BH, Hwang IG, Kim SH, Ling H, Lee GW. Go SI, et al. Oncology. 2014;86(1):1-9. doi: 10.1159/000357136. Epub 2013 Dec 10. Oncology. 2014. PMID: 24335538

2

Phase II study of a biweekly schedule of docetaxel and cisplatin in patients with metastatic non-small cell lung cancer.

Cho SH, Go SI, Lee GW, Kang JH, Kim HG, Kim SH, Cho YJ, Jeong YY, Kim HC, Lee JD, Hwang YS. Cho SH, et al. Among authors: go si. Lung Cancer. 2010 Jul;69(1):94-8. doi: 10.1016/j.lungcan.2009.09.005. Epub 2009 Sep 30. Lung Cancer. 2010. PMID: 19796840 Clinical Trial.

3

A phase II study of irinotecan, continuous 5-fluorouracil, and leucovorin (FOLFIRI) combination chemotherapy for patients with recurrent or metastatic gastric cancer previously treated with a fluoropyrimidine-based regimen.

Kim SH, Lee GW, Go SI, Cho SH, Kim HJ, Kim HG, Kang JH. Kim SH, et al. Among authors: go si. Am J Clin Oncol. 2010 Dec;33(6):572-6. doi: 10.1097/COC.0b013e3181bead7b. Am J Clin Oncol. 2010. PMID: 20042971 Clinical Trial.

4

A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer.

Oh SY, Kwon HC, Jeong SH, Joo YT, Lee YJ, Cho Sh, Kang MH, Go SI, Lee GW, Kim Hg, Kang JH. Oh SY, et al. Among authors: go si. Invest New Drugs. 2012 Feb;30(1):350-6. doi: 10.1007/s10637-010-9507-2. Epub 2010 Aug 13. Invest New Drugs. 2012. PMID: 20706861 Clinical Trial.

5

Hypoxia-inducible factor-1α and excision repair cross-complementing 1 in patients with small cell lung cancer who received front-line platinum-based chemotherapy: a retrospective study.

Lee GW, Go SI, Cho YJ, Jeong YY, Kim HC, Duk Lee J, Hwang YS, Ko GH, Lee JH, Kim DC, Yang JW, Oh S, Lee JS. Lee GW, et al. Among authors: go si. J Thorac Oncol. 2012 Mar;7(3):528-34. doi: 10.1097/JTO.0b013e3182417830. J Thorac Oncol. 2012. PMID: 22258474 Free article.

6

Response to concurrent chemoradiotherapy as a prognostic marker in elderly patients with locally advanced esophageal cancer.

Go SI, Sup Lee W, Hee Kang M, Song HN, Jin Kim M, Jeong Lee M, Kim HG, Won Lee G, Hun Kang J, Lee JH, Mun Kang K, Jeon KN, Min Cho J, Tae Jung W, Hyuck Ko G. Go SI, et al. Tumori. 2012 Mar-Apr;98(2):225-32. doi: 10.1177/030089161209800208. Tumori. 2012. PMID: 22677989

7

Cyclosporine A treatment for relapsed subcutaneous panniculitis-like T-cell lymphoma: a case with long-term follow-up.

Go SI, Lee WS, Kang MH, Kim IS, Kim DC, Lee JH. Go SI, et al. Korean J Hematol. 2012 Jun;47(2):146-9. doi: 10.5045/kjh.2012.47.2.146. Epub 2012 Jun 26. Korean J Hematol. 2012. PMID: 22783363 Free PMC article.

8

Nilotinib-induced interstitial lung disease.

Go SI, Lee WS, Lee GW, Kang JH, Kang MH, Lee JH, Kim HG. Go SI, et al. Int J Hematol. 2013 Sep;98(3):361-5. doi: 10.1007/s12185-013-1398-5. Epub 2013 Jul 23. Int J Hematol. 2013. PMID: 23877149

9

Clinical significance of downstaging in patients with limited-disease small-cell lung cancer.

Go SI, Keam B, Kim TM, Lee SH, Kim DW, Kim HJ, Wu HG, Chung DH, Heo DS. Go SI, et al. Clin Lung Cancer. 2014 Mar;15(2):e1-6. doi: 10.1016/j.cllc.2013.09.003. Epub 2013 Nov 14. Clin Lung Cancer. 2014. PMID: 24356090

10

Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancer.

Go SI, Lee A, Lee US, Choi HJ, Kang MH, Kang JH, Jeon KN, Park MJ, Kim SH, Lee GW. Go SI, et al. Lung Cancer. 2014 Apr;84(1):79-85. doi: 10.1016/j.lungcan.2014.01.014. Epub 2014 Jan 28. Lung Cancer. 2014. PMID: 24524817

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters